Our focus on preparation for the omicron variant of COVID-19 continues. The outbreak of omicron in our community will place demand on our hospital system as we know it will rapidly infect many people. It’s pleasing to see the commencement of the paediatric COVID-19 vaccination this week.
As we head into the peak of our summer the number of people infected by the Delta variant of COVID-19 has declined dramatically with only one active case in Middlemore Hospital at the start of this week.
After a long lockdown in Auckland, and a busy period as the spread of COVID-19 in the community adds pressure to our system, we are looking forward to the new protection framework coming into effect.
Today is day 93 of Auckland’s lockdown, and while public health restrictions have changed and children are returning to school, we urge the community to remain vigilant, continue to follow the rules, and get fully vaccinated.
Aucklanders are grateful for the easing of COVID-19 restrictions after three long months of lockdown. The Government is signally an end to lockdowns and the response to the vaccination call-out is a major contributor as we inch closer to an end to Auckland’s lockdown.
As the number of COVID-19 cases throughout New Zealand increases, more people are curious about the care Middlemore Hospital provides COVID-19 patients. So, some of our clinical leaders have stepped forward to provide insights into what goes on behind the scenes.
Today 288 COVID-19 cases are isolating at households across Auckland, as part of the next step in the region’s COVID-19 community management.
New COVID-19 Protection Framework provides pathway out of lockdown and ability for businesses and events to re-open to vaccinated New Zealanders
Simpler framework to minimise cases and hospitalisations without use of widespread lockdowns
Auckland to move into the new framework when 90 percent of eligible population in each of the three DHBs…
New Zealand is amongst the first countries in the world to sign an advanced purchase agreement for the new COVID-19 oral antiviral treatment molnupiravir from pharmaceutical company Merck Sharp & Dohme (MSD), Prime Minister Jacinda Ardern announced today.